M. Brink, A. Green, and A. B. Bojesen, Physical Health, Medication, and Healthcare Utilization among 70-Year-Old People with Schizophrenia: A Nationwide Danish Register Study, Am J Geriatr Psychiatry, 2017.

A. Brown, D. A. Barton, and G. W. Lambert, Cardiovascular Abnormalities in Patients with Major Depressive Disorder, CNS Drugs, vol.23, issue.7, pp.583-602, 2009.

L. C. Brown, S. R. Majumdar, and J. A. Johnson, Type of antidepressant therapy and risk of type 2 diabetes in people with depression, Diabetes Res Clin Pract, vol.79, issue.1, pp.61-68, 2008.

S. Brown, J. Birtwistle, and L. Roe, The unhealthy lifestyle of people with schizophrenia, Psychological Medicine, vol.29, issue.03, pp.697-701, 1999.

C. I. Cohen, R. Pathak, and P. M. Ramirez, Outcome among community dwelling older adults with schizophrenia: results using five conceptual models, Community Ment Health J, vol.45, issue.2, pp.151-157, 2009.

F. Mcdougall, K. Kvaal, and F. Matthews, Prevalence of depression in older people in England and Wales: the MRC CFA study, Psychol Med, vol.37, pp.1787-95, 2007.

H. Millar, Management of physical health in schizophrenia: a stepping stone to treatment success, Eur Neuropsychopharmacol, vol.18, pp.121-128, 2008.

D. Musil, M. Kaletová, and J. Herman, Venous thromboembolism-prevalence and risk factors in chronic venous disease patients, Phlebology, 2016.

M. A. Nenke, L. A. Hahn, and C. H. Thompson, Psychosis and cardiovascular disease: is diet the missing link?, Schizophr Res, vol.161, issue.2-3, pp.465-70, 2015.

P. Pacher and V. Kecskemeti, Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des, vol.10, pp.2463-75, 2004.

M. Prince, R. Harwood, and R. Blizard, Impairment, disability and handicap as risk factors for depression in old age. The Gospel Oak Project V, Psychol Med, vol.27, pp.311-332, 1997.

M. Prince, R. Harwood, and A. Thomas, A prospective population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late life depression. The Gospel Oak Project VII, Psychol Med, vol.28, pp.337-50, 1998.

C. L. Raison, L. Capuron, and A. H. Miller, Cytokines sing the blues: inflammation and the pathogenesis of depression, Trends Immunol, vol.27, issue.1, pp.24-31, 2006.

P. A. Ringen, J. A. Engh, and A. B. Birkenaes, Increased Mortality in Schizophrenia due to Cardiovascular Disease ? A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions, Front Psychiatry, vol.5, 2014.

C. Roick, A. Fritz-wieacker, and H. Matschinger, Health habits of patients with schizophrenia, Soc Psychiatry Psychiatr Epidemiol, vol.42, issue.4, pp.268-76, 2007.

A. Rozanski, J. A. Blumenthal, and J. Kaplan, Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy, Circulation, vol.99, issue.16, pp.2192-217, 1999.

M. Ryan, P. Collins, and J. H. Thakore, Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia, Am J Psychiatry, vol.160, issue.2, pp.284-293, 2003.

D. Saravane, B. Feve, and Y. Frances, Drawing up guidelines for the attendance of physical health of patients with severe mental illness, Encephale, vol.35, pp.330-339, 2009.

A. J. Scheen, D. Hert, and M. A. , Abnormal glucose metabolism in patients treated with antipsychotics, Diabetes Metab, vol.33, issue.3, pp.169-75, 2007.

J. Schulman and P. A. Shapiro, Depression and cardiovascular disease: what is the correlation? Psychiatric Times, vol.25, pp.41-41, 2008.

M. Sevestre, J. Labarère, and M. Caminzuli, Venous thromboembolism in the elderly: Results of a program to improve prevention, J Mal Vasc, vol.34, issue.5, pp.330-337, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00453682

J. Seymour and T. B. Benning, Depression, cardiac mortality and all-cause mortality, Advances in Psychiatric Treatment, vol.15, issue.2, pp.107-120, 2009.

D. Shimbo, J. Child, and K. Davidson, Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes, The American Journal of Cardiology, vol.89, issue.3, pp.331-334, 2002.

S. M. Stahl, L. Mignon, and J. M. Meyer, Which comes first: atypical antipsychotic treatment or cardiometabolic risk?, Acta Psychiatr Scand, vol.119, issue.3, pp.171-180, 2009.

F. Starrenburg and J. P. Bogers, How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins, Eur Psychiatry, vol.24, issue.3, pp.164-70, 2009.

J. H. Thakore, J. N. Mann, and I. Vlahos, Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia, Int J Obes Relat Metab Disord, vol.26, issue.1, pp.137-178, 2002.

C. T. Van-rossum, H. Van-de-mheen, and J. C. Witteman, Prevalence, treatment, and control of hypertension by sociodemographic factors among the Dutch elderly, Hypertension, vol.35, issue.3, pp.814-835, 2000.

B. Vreeland, Bridging the gap between mental and physical health: a multidisciplinary approach, J Clin Psychiatry, vol.68, issue.4, pp.26-33, 2007.

M. A. Whooley, P. De-jonge, and E. Vittinghoff, Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease, JAMA, vol.300, issue.20, pp.2379-88, 2008.

G. L. Zornberg and H. Jick, Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study, Lancet, vol.356, issue.9237, pp.1219-1242, 2000.

, BIBLIOGRAPHIE 1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 2013.

M. Ruggeri, M. Leese, G. Thornicroft, G. Bisoffi, and M. Tansella, Definition and prevalence of severe and persistent mental illness, Br J Psychiatry, vol.177, pp.149-55, 2000.

, Guideline development group of the Clinical Practice Guideline on Psychosocial Interventions in Severe Mental Illness. Clinical practice guideline on psychosocial interventions in severe mental illness. Madrid: Ministry of Health and Social Policy, 2009.

, Classification internationale des maladies, 10ème édition, 1990.

E. Bleuler, Dementia praecox oder Gruppe der Schizophrenien, 1911.

N. Charrier, K. Chevreul, and I. Durand-zaleski, The cost of schizophrenia: a literature review, Encephale. mai, vol.39, issue.1, pp.49-56, 2013.

S. Hautecouverture, F. Limosin, and F. Rouillon, Epidemiology of schizophrenic disorders. Presse Médicale Paris Fr 1983, mars, vol.35, issue.3, pp.461-469, 2006.

, « Dépression : parlons-en » déclare l'OMS, alors que cette affection arrive en tête des causes de morbidité

. Hippocrate and . Aphorismes, OEuvres complètes d'Hippocrate. Traduction d'E. Littré. Livre IV. 1839

E. Kraepelin and . Psychiatrie, Ein Lehrbuch für Studirende und Aerzte. Band II, p.1899

, World Health Organization. Depression and Other Common Mental Disorders. Global Health Estimates, 2017.

J. Parks, D. Svendsen, P. Singer, M. E. Foti, and B. Mauer, Morbidity and mortality in people with serious mental illness. Alexandria, VA: National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council, p.25, 2006.

C. I. Cohen, P. D. Meesters, and J. Zhao, New perspectives on schizophrenia in later life: implications for treatment, policy, and research, Lancet Psychiatry. Avr, 2015.

A. T. Beekman, J. R. Copeland, and M. J. Prince, Review of community prevalence of depression in later life, Br J Psychiatry, vol.174, issue.4, pp.307-318, 1999.

K. Ritchie, S. Artero, I. Beluche, M. L. Ancelin, A. Mann et al., Prevalence of DSM-IV psychiatric disorders in the French elderly population, Br J Psychiatry, vol.184, pp.147-52, 2004.

D. W. Kay, A. S. Henderson, R. Scott, J. Wilson, D. Rickwood et al., Dementia and depression among the elderly living in the Hobart community : the effect of the diagnostic criteria on the prevalence rates, Psychol Med, pp.15-771, 1985.

J. Copeland, M. E. Dewey, N. Wood, R. Searle, I. A. Davidson et al., Range of mental illnesses amongst the elderly in the community : prevalence in Liverpool using AGECAT, Br J Psychiatry, vol.150, pp.815-838, 1987.

R. E. Roberts, G. A. Kaplan, S. J. Shema, and W. J. Strawbridge, Does growing old increase the risk for depression ?, Am J Psychiatry, vol.154, pp.1384-90, 1997.

D. Seitz, N. Purandare, and D. Conn, Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review, Int Psychogeriatr, 2010.

C. I. Cohen, R. Pathak, P. M. Ramirez, and I. Vahia, Outcome among community dwelling older adults with schizophrenia: results using five conceptual models, Community Ment Health J. avr, vol.45, issue.2, pp.151-157, 2009.

J. Schuster, A. Manetti, M. Aeschimann, and F. Limosin, Epidemiology of psychiatric disorders in elderly and their impact on somatic health. Geriatr Psychol Neuropsychiatr Vieil, vol.11, pp.181-186, 2013.

B. P. Forester and J. R. Gatchel, Medical co-morbidity, brain disease, and the future of geriatric psychiatry, Am J Geriatr Psychiatry, vol.22, issue.11, pp.1061-1066, 2014.

A. Aouba, M. Eb, G. Rey, G. Pavillon, and É. Jougla, Données sur la mortalité en France: principales causes de décès en, 2008.

E. Kraepelin, Dementia Praecox and Paraphrenia, 1919.

B. Malzberg, Mortality Among Patients With Mental Disease, 1934.

W. Essen-moller, Untersuchungen über die Fruchtbarkeit gewisser Gruppen von Geisteskranken, Acta Psychiatr Neurol Suppl, vol.8, pp.1-314, 1935.

C. H. Alstrom, Mortality in mental hospitals with special regard to tuberculosis, Acta Psychiatr Neurol Scand Suppl, vol.24, 1942.

|. Network, Comparative Mortality Risk in Adult Patients With Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in Psychopharmacology Clinical Trials | Oct 01, 2013.

S. Brown, J. Birtwistle, L. Roe, and C. Thompson, The unhealthy lifestyle of people with schizophrenia, Psychological Medicine. Mai, vol.29, issue.03, pp.697-701, 1999.

P. Pacher and V. Kecskemeti, Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?, Curr Pharm Des, vol.10, issue.20, pp.2463-75, 2004.

A. H. Glassman and J. T. Bigger, Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death, Am J Psychiatry, vol.158, issue.11, pp.1774-82, 2001.

M. De-hert, C. U. Correll, J. Bobes, M. Cetkovich-bakmas, D. Cohen et al., Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care, World Psychiatry. Févr, vol.10, issue.1, pp.52-77, 2011.

C. U. Correll, J. Detraux, J. De-lepeleire, D. Hert, and M. , Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder, World Psychiatry. Juin, 2015.

L. C. Brown, S. R. Majumdar, and J. A. Johnson, Type of antidepressant therapy and risk of type 2 diabetes in people with depression, Diabetes Res Clin Pract. Janv, 2008.

R. Rugulier, Depression as a predictor for coronary heart disease, a review and meta-analysis, American J Prev Med, vol.23, pp.51-61, 2002.

S. S. Mahmood, D. Levy, R. S. Vasan, and T. J. Wang, The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective, Lancet, vol.383, issue.9921, pp.999-1008, 2014.

D. Agostino, R. B. Vasan, R. S. Pencina, M. J. Wolf, P. A. Cobain et al., General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation, vol.117, pp.743-53, 2008.

M. De-hert, C. U. Correll, J. Bobes, M. Cetkovich-bakmas, D. Cohen et al., Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care, World Psychiatry, vol.10, pp.52-77, 2011.

Q. Foguet-boreu, M. I. Fernandez-san-martin, F. Mateo, G. , Z. Del-olmo et al., Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and metaanalysis. BMC Psychiatry, vol.16, 2016.

M. De-hert, J. M. Dekker, D. Wood, K. G. Kahl, R. Holt et al., Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC), European Psychiatry. Sept, vol.24, issue.6, pp.412-436, 2009.

R. Holt and R. Peveler, Obesity, serious mental illness and antipsychotic drugs, Diabetes Obes Metab, vol.11, pp.665-79, 2009.

L. V. Kessing, A. F. Thomsen, and U. B. Mogensen, Treatment with antipsychotics and the risk of diabetes in clinical practice, Br J Psychiatry, vol.197, pp.266-71, 2010.

C. U. Correll, A. M. Frederickson, J. M. Kane, and P. Manu, Does Antipsychotic Polypharmacy Increase the Risk for Metabolic Syndrome? Schizophr Res, Janv, vol.89, issue.1-3, pp.91-100, 2007.

C. U. Correll, A. M. Frederickson, J. M. Kane, and P. Manu, Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs, J Clin Psychiatry. 15 avr, vol.67, issue.4, pp.575-83, 2006.

L. Maayan and C. U. Correll, Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents, Journal of Child and Adolescent Psychopharmacology. 1 déc, vol.21, issue.6, pp.517-552, 2011.

R. H. Dovenmuehle and A. Verwoerdt, Physical Illness and Depressive Symptomatology

I. , Incidence of Depressive Symptoms in Hospitalized Cardiac Patients, Journal of the American Geriatrics Society, vol.10, issue.11, pp.932-979, 1962.

A. E. Hussar, Coronary Heart Disease in Chronic Schizophrenic Patients. Circulation. 1 juin, vol.31, issue.6, pp.919-948, 1965.

J. Seymour and T. B. Benning, Depression, cardiac mortality and all-cause mortality, Advances in Psychiatric Treatment. 1 mars, vol.15, issue.2, pp.107-120, 2009.

A. Brown, D. A. Barton, and G. W. Lambert, Cardiovascular Abnormalities in Patients with Major Depressive Disorder, CNS Drugs. Juill, vol.23, issue.7, pp.583-602, 2009.

S. Mallik, J. A. Spertus, K. J. Reid, H. M. Krumholz, J. S. Rumsfeld et al.,

, Depressive Symptoms After Acute Myocardial Infarction: Evidence for Highest Rates in Younger Women, Arch Intern Med. 24 avr, vol.166, issue.8, pp.876-83, 2006.

R. C. Ziegelstein, Improving depression and reducing cardiac events: which is the chicken and which is the egg?, J Psychosom Res. Mai, vol.74, issue.5, pp.454-461, 2013.

A. A. Ariyo, M. Haan, C. M. Tangen, J. C. Rutledge, M. Cushman et al.,

, Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans, Circulation, vol.102, issue.15, pp.1773-1782, 2000.

D. Adamis and C. Ball, Physical morbidity in elderly psychiatric inpatients: prevalence and possible relations between the major mental disorders and physical illness, Int J Geriat Psychiatry. 1 mars, vol.15, issue.3, pp.248-53, 2000.

D. C. Goff, L. M. Sullivan, J. P. Mcevoy, J. M. Meyer, H. A. Nasrallah et al., A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls, Schizophrenia Research, 2005.

L. C. Bresee, S. R. Majumdar, S. B. Patten, and J. A. Johnson, Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study

, Schizophr Res, vol.117, issue.1, pp.75-82, 2010.

M. De-hert, J. M. Dekker, D. Wood, K. G. Kahl, R. Holt et al., Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC), Eur Psychiatry. sept, vol.24, issue.6, pp.412-436, 2009.

R. Peters, E. Pinto, N. Beckett, C. Swift, J. Potter et al., Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET), Age Ageing. 7 janv, 2010.

M. Clerici, F. Bartoli, D. Carretta, C. Crocamo, P. Bebbington et al., Cardiovascular risk factors among people with severe mental illness in Italy: a cross-sectional comparative study, Gen Hosp Psychiatry, vol.36, issue.6, pp.698-702, 2014.

D. Osborn, S. Hardoon, R. Z. Omar, R. Holt, M. King et al., Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program, JAMA Psychiatry, 2015.

. Insee, Projections de population 2005-2050. Isabelle Robert-Bobée, Economies et statistiques. N°1. P, pp.95-112, 2007.

Z. Fan, Y. Wu, J. Shen, J. T. Zhan, and R. , Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies, J Psychiatr Res, 2013.

C. Arbus, J. Clement, T. Bougerol, P. Fremont, S. Lancrenon et al., Health management of older persons with chronically medicated psychotic disorders: the results of a survey in France, Int Psychogeriatr, vol.24, issue.3, pp.496-502, 2012.

F. Rouillon, E. Van-ganse, P. Vekhoff, R. Arnaud, L. Depret-bixio et al., Vigilance level for cardiovascular risk factors in schizophrenic patients

. Encephale, , vol.41, pp.70-77, 2015.

M. F. Piepoli, A. W. Hoes, S. Agewall, C. Albus, C. Brotons et al., , 2016.

, European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), Eur Heart J, vol.37, issue.29, pp.2315-81, 2016.

, Haute Autorité de Santé-Label de la HAS-Comment améliorer la prise en charge somatique des patients ayant une pathologie psychiatrique sévère et chronique

H. Millar, Management of physical health in schizophrenia: a stepping stone to treatment success, Eur Neuropsychopharmacol, vol.18, issue.2, pp.121-128, 2008.

, Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update), 2009.

M. De-hert, R. Van-winkel, D. Van-eyck, L. Hanssens, M. Wampers et al., Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study, Clin Pract Epidemiol Ment Health, vol.2, p.14, 2006.

A. J. Mitchell, D. Vancampfort, D. Herdt, A. Yu, W. et al., Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients, Schizophr Bull, vol.39, issue.2, pp.295-305, 2013.

A. J. Mitchell, D. Hert, and M. , Promotion of physical health in persons with schizophrenia: can we prevent cardiometabolic problems before they begin?, Acta Psychiatr Scand, vol.132, issue.2, pp.83-88, 2015.

M. Brink, A. Green, A. B. Bojesen, J. S. Lamberti, Y. Conwell et al., Physical Health, Medication, and Healthcare Utilization among 70-Year-Old People with Schizophrenia: A Nationwide Danish Register Study, Am J Geriatr Psychiatry, 2009.

H. W. Konz, P. D. Meesters, N. Paans, D. S. Van-grootheest, H. C. Comijs et al., Screening for metabolic syndrome in older patients with severe mental illness

, Am J Geriatr Psychiatry, vol.22, issue.11, pp.1116-1136, 2014.